Literature DB >> 20346210

Some problems in the surgical treatment of gastric cancer.

Xiao-Na Wang1, Han Liang.   

Abstract

Gastric cancer is one of the most common cancers in the world. Surgery is the most important therapy for gastric cancer. Individual treatment strategies for patients suffering from gastric cancer according to the different tumor node metastasis (TNM) stage would improve the survival rate in a maximum degree, and improve the patient quality-of-life. This article reviewed some problems in the surgical treatment of gastric cancer.

Entities:  

Mesh：

Year:  2010        PMID： 20346210     DOI： 10.5732/cjc.009.10629

Source DB:  PubMed          Journal:  Chin J Cancer        ISSN： 1944-446X


  13 in total

1.  LncRNA-AP001631.9 promotes cell migration in gastric cancer.

Authors:  Hui Cai; Xiaojuan Ye; Bin He; Qiang Li; Yandong Li; Yong Gao
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

2.  Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer.

Authors:  Giuseppe Verlato; Simone Giacopuzzi; Maria Bencivenga; Paolo Morgagni; Giovanni De Manzoni
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

3.  Prognostic Impact of the Metastatic Lymph Node Ratio on Survival in Gastric Cancer.

Authors:  Wafi Attaallah; Kivilcim Uprak; Omer Gunal; Cumhur Yegen
Journal:  Indian J Surg Oncol       Date:  2016-01-09

4.  L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer.

Authors:  Dong-liang Chen; Zhao-lei Zeng; Jing Yang; Chao Ren; De-shen Wang; Wen-jing Wu; Rui-hua Xu
Journal:  J Hematol Oncol       Date:  2013-06-27       Impact factor: 17.388

5.  Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition.

Authors:  Yu Fan; Yan-Fen Wang; Hua-Fang Su; Na Fang; Chen Zou; Wen-Feng Li; Zheng-Hua Fei
Journal:  J Hematol Oncol       Date:  2016-07-21       Impact factor: 17.388

6.  The pseudogene derived long noncoding RNA DUXAP8 promotes gastric cancer cell proliferation and migration via epigenetically silencing PLEKHO1 expression.

Authors:  Hong-Wei Ma; Min Xie; Ming Sun; Tian-Yu Chen; Rong-Rong Jin; Tian-Shi Ma; Qin-Nan Chen; Er-Bao Zhang; Xue-Zhi He; Wei De; Zhi-Hong Zhang
Journal:  Oncotarget       Date:  2016-08-05

7.  miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer.

Authors:  Yuejuan Xu; Jue Sun; Jianhua Xu; Qi Li; Yuewu Guo; Qiang Zhang
Journal:  Gastroenterol Res Pract       Date:  2012-06-27       Impact factor: 2.260

8.  Lymph node ratio is a better prognosticator than lymph node status for gastric cancer: A retrospective study of 138 cases.

Authors:  Wei-Juan Zeng; Wen-Qin Hu; Lin-Wei Wang; Shu-Guang Yan; Jian-Ding Li; Hao-Liang Zhao; Chun-Wei Peng; Gui-Fang Yang; Yan Li
Journal:  Oncol Lett       Date:  2013-10-10       Impact factor: 2.967

9.  Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression.

Authors:  Tong-Peng Xu; Ming-de Huang; Rui Xia; Xin-Xin Liu; Ming Sun; Li Yin; Wen-Ming Chen; Liang Han; Er-Bao Zhang; Rong Kong; Wei De; Yong-Qian Shu
Journal:  J Hematol Oncol       Date:  2014-08-29       Impact factor: 17.388

10.  Long noncoding RNA HOXA-AS2 promotes gastric cancer proliferation by epigenetically silencing P21/PLK3/DDIT3 expression.

Authors:  Min Xie; Ming Sun; Ya-nan Zhu; Rui Xia; Yan-wen Liu; Jie Ding; Hong-wei Ma; Xue-zhi He; Zhi-hong Zhang; Zhi-jun Liu; Xiang-hua Liu; Wei De
Journal:  Oncotarget       Date:  2015-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.